Pathogenesis ceftriaxone-associated biliary sludge vitro studies calcium-ceftriaxone binding solubility Ceftriaxone semisynthetic third-generation cephalosporin biliary sludge formation Analysis biliary concretions agent calcium salt ceftriaxone present vitro studies insight pathogenesis ceftriaxone-associated biliary sludge formation possible interactions calcium bile salts ceftriaxone Ceftriaxone high calcium-binding affinity formation constant calcium ceftriaxone salt degrees L/mol stoichiometry salt calcium ceftriaxone calcium-binding property ceftriaxone additive taurocholate mixed taurocholate-ceftriaxone solutions solubility product constant calcium ceftriaxone metastability visible microscopic precipitates ceftriaxone ion product solubility product constant factor Metastability calcium ceftriaxone salt human gallbladder bile vitro Estimates human biliary calcium ceftriaxone solubility vivo previously-reported values biliary ceftriaxone solubility product constant study saturation indices calcium-ceftriaxone human bile decrease solubility ceftriaxone dose doses equal saturation index metastable range calcium-salt doses equal saturation index metastable limit conditions precipitation ceftriaxone development ceftriaxone-induced biliary sludge solubility problem patients high-dose treatment equal study risk ceftriaxone-associated biliary pseudolithiasis increases ceftriaxone dose patients impaired gallbladder emptying 